Janssen: Response to TB CAB letter

Janssen Pharmaceutical Companies of Johnson & Johnson
June 12, 2012, 8:36 p.m.
post image

Janssen's response to TB CAB letter regarding pharmacokinetic studies, paediatric studies, and compassionate use of bedaquiline.

Download the letter from here.